tag:blogger.com,1999:blog-33960805.post116443243436591833..comments2023-10-30T02:03:47.513-07:00Comments on Clinical Psychology and Psychiatry: A Closer Look: NYT: Kids Taking Lots of Psych Meds...CL Psychhttp://www.blogger.com/profile/13990549972520745769noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-33960805.post-1164829427393353762006-11-29T11:43:00.000-08:002006-11-29T11:43:00.000-08:00I'm not a doctor, or psychologist, but I found tha...I'm not a doctor, or psychologist, but I found that article frightening - especially the bit about the three year old. To me, that sounded like a three year old, not a kid who needed three different psychiatric drugs. Glad to see that someone closer to the field thought the same.Magpiehttps://www.blogger.com/profile/15460136246441367993noreply@blogger.comtag:blogger.com,1999:blog-33960805.post-1164618654231726452006-11-27T01:10:00.000-08:002006-11-27T01:10:00.000-08:00As is your custom, very interesting comment. I am...As is your custom, very interesting comment. I am not familiar with the backgrounds of everyone in the article, so if indeed some psychiatrists are talking in a two faced manner about medication, that is unfortunate, though I’d also say it’s not very surprising.<BR/><BR/>My familiarity was Daniel Safer’s work is greater than any of the other docs in the article, and, at least in the past few years, I’ve noticed that his research has found disparities between racial groups in terms of psych med prescriptions, but I don’t recall his mentioning that this means that groups receiving fewer meds (i.e., non-Whites) should receive more meds. His conclusions, at least the ones that I recall, were merely descriptive, not a call for mass drugging. Plus he’s also written some thoughtful pieces regarding the drug industry (one is linked in the original post) that I would certainly not take as drug-promoting. However, he may well have changed his views over time; I don’t know. <BR/><BR/>“Now that the winds are decidedly anti-Pharma, all of these guys come out against the medications on which they built their careers-- but only now that it's safe.<BR/><BR/>Now these academics are against SSRIs (all generic) and Depakote (generic) but you can't find one against Lamictal (not generic.) funny how that happened.”<BR/><BR/>Great point overall. I can’t necessarily point fingers at any particular individuals on this one, likely due to my own ignorance, but the point that the “key opinion leaders” tend to hail new expensive treatments over older, cheaper, and generally equally efficacious products is certainly a sign that the relationship between the industry and academics has become far too cozy.CL Psychhttps://www.blogger.com/profile/13990549972520745769noreply@blogger.com